New York-based virtual women's health provider Maven Clinic is partnering with health-tracking ring maker Oura to allow Oura Ring wearers to sync their data with the Maven platform. Maven Clinic is a ...

Viz.ai, a company involved in AI-backed imaging and care coordination, is collaborating with pharma giant Novartis to develop proprietary AI-powered workflows inside the Viz Oncology Suite. Viz.ai ...

Population health technology company Color announced it had laid off workers as it pivots focus away from COVID-19 testing. According to posts by former employees on LinkedIn, the company cut 300 jobs ...

Ellipsis Health, a company using AI voice agent technology, announced it has raised $45 million in a new Series A funding round. Salesforce, Khosla Ventures and CVS Health Ventures led the round.

Connor Glass, founder and CEO of Phantom Neuro, explains how the company's muscle-machine interface for amputees is enabling the development of advanced prosthetic limbs designed to function as ...

Editor's note: This article has been updated with a comment from Hims & Hers CEO and the company. Pharma giant Novo Nordisk announced that it is terminating its contract with direct-to-consumer ...

"The FDA's clearance of SleepioRx is a landmark milestone for Big Health and provides accessible, guideline-recommended, first-line treatment for insomnia." Big Health CEO Yael Berman said in a ...

BrainCheck, a digital health company specializing in cognitive assessments, announced it secured $15 million in funding. The investment was led by seed-stage investor Next Coast Ventures, venture ...

By HIMSS TV September 25, 2024 06:00 am Share Tags: clinical AI ...

InSilicoTrials, a health tech company that develops AI-based simulation to predict drug safety and efficacy in the drug development process, announced it has been accepted into the Microsoft for ...

Elephas, an oncology-focused diagnostics platform, announced it secured $55 million in Series C funding, bringing its total raise to $116.5 million. Venture Investors Health Fund and the State of ...

Glucose monitoring specialist Dexcom announced it received FDA clearance for its G7 15 Day continuous glucose monitoring (CGM) system for people 18 and older with type 1, type 2 and gestational ...